Your browser doesn't support javascript.
loading
Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids.
Meraviglia, Viviana; Zanon, Alessandra; Lavdas, Alexandros A; Schwienbacher, Christine; Silipigni, Rosamaria; Di Segni, Marina; Chen, Huei-Sheng Vincent; Pramstaller, Peter P; Hicks, Andrew A; Rossini, Alessandra.
Afiliación
  • Meraviglia V; Center for Biomedicine, European Academy Bozen/Bolzano (EURAC).
  • Zanon A; Center for Biomedicine, European Academy Bozen/Bolzano (EURAC).
  • Lavdas AA; Center for Biomedicine, European Academy Bozen/Bolzano (EURAC).
  • Schwienbacher C; Center for Biomedicine, European Academy Bozen/Bolzano (EURAC).
  • Silipigni R; Laboratory of Medical Genetics, Fondazione IRCCS Ca´ Granda, Ospedale Maggiore Policlinico.
  • Di Segni M; Laboratory of Medical Genetics, Fondazione IRCCS Ca´ Granda, Ospedale Maggiore Policlinico.
  • Chen HS; Del E. Webb Center for Neuroscience, Aging & Stem Cell Research, Sanford-Burnham Medical Research Institute.
  • Pramstaller PP; Center for Biomedicine, European Academy Bozen/Bolzano (EURAC).
  • Hicks AA; Center for Biomedicine, European Academy Bozen/Bolzano (EURAC).
  • Rossini A; Center for Biomedicine, European Academy Bozen/Bolzano (EURAC); Alessandra.Rossini@eurac.edu.
J Vis Exp ; (100): e52885, 2015 Jun 05.
Article en En | MEDLINE | ID: mdl-26131963
ABSTRACT
Somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs) by forcing the expression of four transcription factors (Oct-4, Sox-2, Klf-4, and c-Myc), typically expressed by human embryonic stem cells (hESCs). Due to their similarity with hESCs, iPSCs have become an important tool for potential patient-specific regenerative medicine, avoiding ethical issues associated with hESCs. In order to obtain cells suitable for clinical application, transgene-free iPSCs need to be generated to avoid transgene reactivation, altered gene expression and misguided differentiation. Moreover, a highly efficient and inexpensive reprogramming method is necessary to derive sufficient iPSCs for therapeutic purposes. Given this need, an efficient non-integrating episomal plasmid approach is the preferable choice for iPSC derivation. Currently the most common cell type used for reprogramming purposes are fibroblasts, the isolation of which requires tissue biopsy, an invasive surgical procedure for the patient. Therefore, human peripheral blood represents the most accessible and least invasive tissue for iPSC generation. In this study, a cost-effective and viral-free protocol using non-integrating episomal plasmids is reported for the generation of iPSCs from human peripheral blood mononuclear cells (PBMNCs) obtained from frozen buffy coats after whole blood centrifugation and without density gradient separation.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Plásmidos / Células Madre Pluripotentes Inducidas Tipo de estudio: Guideline Aspecto: Ethics Límite: Humans Idioma: En Revista: J Vis Exp Año: 2015 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Plásmidos / Células Madre Pluripotentes Inducidas Tipo de estudio: Guideline Aspecto: Ethics Límite: Humans Idioma: En Revista: J Vis Exp Año: 2015 Tipo del documento: Article